Drug Safety in Developing Countries

Drug Safety in Developing Countries
Author: Yaser Mohammed Al-Worafi
Publsiher: Academic Press
Total Pages: 686
Release: 2020-06-03
ISBN 10: 0128204125
ISBN 13: 9780128204122
Language: EN, FR, DE, ES & NL

Drug Safety in Developing Countries Book Review:

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues Describes current achievements of drug safety practice in developing countries Addresses the challenges of drug safety in developing countries Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety

Drug Safety in Developing Countries

Drug Safety in Developing Countries
Author: Yaser Mohammed Al-Worafi
Publsiher: Academic Press
Total Pages: 320
Release: 2020-06-04
ISBN 10: 9780128198377
ISBN 13: 0128198370
Language: EN, FR, DE, ES & NL

Drug Safety in Developing Countries Book Review:

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues Describes current achievements of drug safety practice in developing countries Addresses the challenges of drug safety in developing countries Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety

Drug Benefits and Risks

Drug Benefits and Risks
Author: Chris J. van Boxtel,Budiono Santoso,I. Ralph Edwards
Publsiher: John Wiley & Sons
Total Pages: 734
Release: 2001-11-28
ISBN 10: 9780471899273
ISBN 13: 0471899275
Language: EN, FR, DE, ES & NL

Drug Benefits and Risks Book Review:

This is an inclusive reference exploring the scientific basis and practice of drug therapy. The key concept is to look at the balance between the benefits and risks of drugs but in this context also the social impact which drugs have in modern societies is highlighted. Taking an evidence-based approach to the problem, the practice of clinical pharmacology and pharmacotherapy in the developing as well as the developed world is examined. For this purpose the book * Covers general clinical pharmacology, pharmacology of various drug groups and the treatments specific to various diseases * Gives guidance on how doctors should act so that drugs can be used effectively and safely * Encourages the rational use of drugs in society This book brings together a large amount of excellent content that will be invaluable for anyone working within, or associated with, the field of clinical pharmacology and pharmacotherapy - undergraduates, postgraduates, regulatory authorities and the pharmaceutical industry.

Countering the Problem of Falsified and Substandard Drugs

Countering the Problem of Falsified and Substandard Drugs
Author: Institute of Medicine,Board on Global Health,Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products
Publsiher: National Academies Press
Total Pages: 376
Release: 2013-06-20
ISBN 10: 0309269393
ISBN 13: 9780309269391
Language: EN, FR, DE, ES & NL

Countering the Problem of Falsified and Substandard Drugs Book Review:

The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

Drug Safety Amendments of 1976

Drug Safety Amendments of 1976
Author: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment
Publsiher: Unknown
Total Pages: 545
Release: 1976
ISBN 10: 1928374650XXX
ISBN 13: UOM:39015081219258
Language: EN, FR, DE, ES & NL

Drug Safety Amendments of 1976 Book Review:

Illicit Medicines in the Global South

Illicit Medicines in the Global South
Author: Mathieu Quet
Publsiher: Routledge
Total Pages: 232
Release: 2021-10-21
ISBN 10: 1000463249
ISBN 13: 9781000463248
Language: EN, FR, DE, ES & NL

Illicit Medicines in the Global South Book Review:

This book investigates pharmaceutical regulation and the public health issue of fake or illicit medicines in developing countries. The book analyses the evolution of pharmaceutical capitalism, showing how the entanglement of market and health interests has come to shape global regulation. Drawing on extensive fieldwork in India, Kenya and Europe, it demonstrates how large pharmaceutical companies have used the fight against fake medicines to serve their strategic interests and protect their monopolies, sometimes to the detriment of access to medicines in developing countries. The book investigates how the contemporary dynamics of pharmaceutical power in global markets have gone on to shape societies locally, resulting in more security-oriented policies. These processes highlight the key consequences of contemporary "logistical regimes" for access to health. Providing important insights on how the flows of commodities, persons, and knowledge shape contemporary access to medicines in the developing countries, this book will be of considerable interest to policy makers and regulators, and to scholars and students across sociology, science and technology studies, global health, and development studies.

Social and Administrative Aspects of Pharmacy in Low and Middle Income Countries

Social and Administrative Aspects of Pharmacy in Low  and Middle Income Countries
Author: Mohamed Izham Mohamed Ibrahim,Albert Wertheimer,Zaheer-Ud-Din Babar
Publsiher: Academic Press
Total Pages: 484
Release: 2017-10-31
ISBN 10: 0128112298
ISBN 13: 9780128112298
Language: EN, FR, DE, ES & NL

Social and Administrative Aspects of Pharmacy in Low and Middle Income Countries Book Review:

Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions examines the particularities of low- and middle-income countries and offers solutions based on their needs, culture and available resources. Drawing from the firsthand experience of researchers and practitioners working in these countries, this book addresses the socio-behavioral aspects of pharmacy and health, pharmacoeconomics, pharmaceutical policy, supply management and marketing, pharmacoepidemiology and public health pharmacy specific to low- and middle-income countries. While some practices may be applied appropriately in disparate places, too often pharmacy practice in low- and middle-income countries is directly copied from successes in developed countries, despite the unique needs and challenges low- and middle-income countries face. Examines key issues and challenges of pharmacy practice and the pharmaceutical sector specific to low- and middle-income countries Compares pharmacy practice in developed and developing countries to highlight the unique challenges and opportunities of each Provides a blueprint for the future of pharmacy in low- and middle-income countries, including patient-centered care, evidence-based care and promoting the role of the pharmacist for primary health care in these settings

Global Health Interventions for U S Food and Drug Safety

Global Health Interventions for U S  Food and Drug Safety
Author: Anonim
Publsiher: Unknown
Total Pages: 20
Release: 2009
ISBN 10: 1928374650XXX
ISBN 13: OCLC:497953909
Language: EN, FR, DE, ES & NL

Global Health Interventions for U S Food and Drug Safety Book Review:

Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad

Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad
Author: Institute of Medicine,Board on Health Sciences Policy,Board on Global Health,Committee on Strengthening Core Elements of Food and Drug Regulatory Systems in Developing Countries
Publsiher: National Academies Press
Total Pages: 366
Release: 2012-09-03
ISBN 10: 030922408X
ISBN 13: 9780309224086
Language: EN, FR, DE, ES & NL

Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad Book Review:

A very high portion of the seafood we eat comes from abroad, mainly from China and Southeast Asia, and most of the active ingredients in medicines we take originate in other countries. Many low- and middle-income countries have lower labor costs and fewer and less stringent environmental regulations than the United States, making them attractive places to produce food and chemical ingredients for export. Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad explains that the diversity and scale of imports makes it impractical for U.S. Food and Drug Administration (FDA) border inspections to be sufficient to ensure product purity and safety, and incidents such as American deaths due to adulterated heparin imported from China propelled the problem into public awareness. The Institute of Medicine Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries took up the vital task of helping the FDA to cope with the reality that so much of the food, drugs, biologics, and medical products consumed in the United States originate in countries with less-robust regulatory systems. Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad describes the ways the United States can help strengthen regulatory systems in low and middle income countries and promote cross-border partnerships - including government, industry, and academia - to foster regulatory science and build a core of regulatory professionals. This report also emphasizes an array of practical approaches to ensure sound regulatory practices in today's interconnected world.

Children and Drug Safety

Children and Drug Safety
Author: Cynthia A Connolly
Publsiher: Rutgers University Press
Total Pages: 260
Release: 2018-05-11
ISBN 10: 0813563895
ISBN 13: 9780813563893
Language: EN, FR, DE, ES & NL

Children and Drug Safety Book Review:

Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance—many of the drugs administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children’s risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable.

Drug Labeling in Developing Countries

Drug Labeling in Developing Countries
Author: United States
Publsiher: Congress
Total Pages: 193
Release: 1993
ISBN 10: 1928374650XXX
ISBN 13: UIUC:30112023352823
Language: EN, FR, DE, ES & NL

Drug Labeling in Developing Countries Book Review:

Quantitative Evaluation of Safety in Drug Development

Quantitative Evaluation of Safety in Drug Development
Author: Qi Jiang,H. Amy Xia
Publsiher: CRC Press
Total Pages: 382
Release: 2014-12-08
ISBN 10: 1466555475
ISBN 13: 9781466555471
Language: EN, FR, DE, ES & NL

Quantitative Evaluation of Safety in Drug Development Book Review:

State-of-the-Art Methods for Drug Safety Assessment Responding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and observational studies in biopharmaceutical product development. It presents the latest statistical methods for drug safety assessment. The book’s three sections focus on study design, safety monitoring, and data evaluation/analysis. The book addresses key challenges across regulatory agencies, industry, and academia. It discusses quantitative approaches to safety evaluation and risk management in drug development, covering Bayesian methods, effective safety graphics, and risk-benefit evaluation. Written by a team of experienced leaders, this book brings the most advanced knowledge and statistical methods of drug safety to the statistical, clinical, and safety community. It shares best practices and stimulates further research and methodology development in the drug safety area.

Safety of Medicines with Respect to Drug Counterfeiting in Developing Countries

Safety of Medicines with Respect to Drug Counterfeiting in Developing Countries
Author: Ahmed Elmi
Publsiher: Unknown
Total Pages: 135
Release: 2013
ISBN 10: 1928374650XXX
ISBN 13: OCLC:870421544
Language: EN, FR, DE, ES & NL

Safety of Medicines with Respect to Drug Counterfeiting in Developing Countries Book Review:

Disease Control Priorities in Developing Countries

Disease Control Priorities in Developing Countries
Author: Dean T. Jamison,Joel G. Breman,Anthony R. Measham,George Alleyne,Mariam Claeson,David B. Evans,Prabhat Jha,Anne Mills,Philip Musgrove
Publsiher: World Bank Publications
Total Pages: 1452
Release: 2006-04-02
ISBN 10: 0821361805
ISBN 13: 9780821361801
Language: EN, FR, DE, ES & NL

Disease Control Priorities in Developing Countries Book Review:

Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.

Drug Benefits and Risks

Drug Benefits and Risks
Author: Christoffel Jos van Boxtel,Budiono Santoso,I. Ralph Edwards
Publsiher: IOS Press
Total Pages: 821
Release: 2008-01-01
ISBN 10: 158603880X
ISBN 13: 9781586038809
Language: EN, FR, DE, ES & NL

Drug Benefits and Risks Book Review:

Explores the scientific basis and practice of drug therapy. This book examines the practice of clinical pharmacology and pharmacotherapy in the developing as well as the developed world. It covers general clinical pharmacology, pharmacology of various drug groups and the treatments specific to various diseases.

Industrial Guide to Chemical and Drug Safety

Industrial Guide to Chemical and Drug Safety
Author: T. S. S. Dikshith,Prakash V. Diwan
Publsiher: John Wiley & Sons
Total Pages: 664
Release: 2003-05-27
ISBN 10: 0471458775
ISBN 13: 9780471458777
Language: EN, FR, DE, ES & NL

Industrial Guide to Chemical and Drug Safety Book Review:

Exposure to a wide variety of chemicals and drugs has become common in industrial, laboratory, and even household environments. Fortunately, global understanding and consequently global safety standards regarding the management of toxic and hazardous substances are fast approaching uniformity. The methods of handling, use, transportation, storage, and disposal in particular are moving toward standardization. As these protocols involving chemicals and drugs continue to cross international borders, students and professionals need a reliable resource to ensure they observe appropriate safety standards. The Industrial Guide to Chemical and Drug Safety covers not only current standards, but also a wealth of information on toxins to help regulatory bodies develop new protocols. Written in an accessible narrative style, the Guide covers chemicals by key classes such as solvents, pesticides, and metals, and also by key industries such as drugs, food additives, plastics, cosmetics, detergents, and soaps. The book explains the beneficial and harmful aspects of a broad range of materials to which students, trainees, skilled workers, managers, and personnel associated with regulatory agencies are exposed, with the purpose of helping them avoid the illnesses associated with the misuse of chemicals and drugs. Chapters include: -Heavy Metals -Pesticides -Industrial Solvents -Industrial Gases and Fumes -Drugs -Target Organ Toxicity -Disposal of Hazardous Chemicals -Guidance to Students and Workers -Good Laboratory Practice

Practical Drug Safety from A to Z

Practical Drug Safety from A to Z
Author: Barton Cobert,Pierre Biron
Publsiher: Jones & Bartlett Publishers
Total Pages: 402
Release: 2009-10-06
ISBN 10: 0763745278
ISBN 13: 9780763745271
Language: EN, FR, DE, ES & NL

Practical Drug Safety from A to Z Book Review:

The Dictionary of Drug Safety and Pharmacovigilance is an alphabetical guide to drug safety monitoring (pharmacovigilance), covering literally, the

Improving Drug Safety A Joint Responsibility

Improving Drug Safety     A Joint Responsibility
Author: Rolf Dinkel,Bruno Horisberger,Kenneth W. Tolo
Publsiher: Springer Science & Business Media
Total Pages: 338
Release: 2013-03-07
ISBN 10: 3642612504
ISBN 13: 9783642612503
Language: EN, FR, DE, ES & NL

Improving Drug Safety A Joint Responsibility Book Review:

As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety? In April 1990, this question became the theme for a conference at Wolfsberg, Switzerland, near the shores of Lake Constance. Called an "international dialogue conference" by its organizers, the meeting brought together leaders from the pharmaceutical industry, regulatory authorities, academia, medicine, consumer organizations and the media. Opening addresses were given by representatives of the Council for International Organizations of Medical Sciences (CIOMS), the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), the Swiss International Pharmaceutical Agency, and the RAD-AR Consortium. This book documents the papers presented and discussions held at this conference, which took the topic of risks and benefits of drug therapy one step further to responsibility. It includes a rich menu of issues for those who care about the evaluation of drug therapy, the ethics behind it, the expectations of the patient, and the role of traditional and nontraditional drug safety communica tions. The ideas expressed here come from different parts of the world but relate to common drug safety problems, observations, and scientific assessments; they provide insights into innovative approaches, cautious changes, and desired actions. The papers in this volume are broadly divided into conceptual perspectives (ethics, how the knowledge about drug risks and benefits is generated and appraised, the expectations in drug safety) and operational perspectives (communication, discussion, and action).

Drug Safety and Pricing

Drug Safety and Pricing
Author: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Publsiher: Unknown
Total Pages: 117
Release: 2000
ISBN 10: 1928374650XXX
ISBN 13: PSU:000047032026
Language: EN, FR, DE, ES & NL

Drug Safety and Pricing Book Review:

Cobert s Manual of Drug Safety and Pharmacovigilance

Cobert s Manual of Drug Safety and Pharmacovigilance
Author: Barton Cobert
Publsiher: Jones & Bartlett Publishers
Total Pages: 407
Release: 2011-04-01
ISBN 10: 0763791598
ISBN 13: 9780763791599
Language: EN, FR, DE, ES & NL

Cobert s Manual of Drug Safety and Pharmacovigilance Book Review:

Rev. ed. of: Manual of drug safety and pharmacovigilance / Barton L. Cobert. c2007.